Logo
Logo
Get startedLogin

Treatments

GLP-1 Weight Loss

Build Muscle

Increase Energy

Cognitive Health

Hair, Skin & Nails

Hormone Therapy

Repair & Recovery

Sexual Wellness

Vitamins & Nutrients

Company

About Us

How It Works

Partners

FAQ

Elamipretide (SS-31)

Actual medication label and appearance may vary

Peptide Treatment

Elamipretide (SS-31)

Elamipretide (SS-31) is a mitochondria-targeted peptide that concentrates in the inner mitochondrial membrane to restore energy production, reduce oxidative stress, and support cellular vitality. It is used in longevity and energy optimization protocols.

Check eligibility

Why it works

Key benefits

  • Targets the inner mitochondrial membrane directly for maximum effect
  • Stabilizes the electron transport chain for efficient energy production
  • Reduces oxidative stress and mitochondrial damage
  • FDA Breakthrough Therapy designation demonstrates clinical recognition
  • Supports patients with fatigue, energy decline, and mitochondrial dysfunction
  • Cutting-edge longevity peptide backed by clinical trial data

Mechanism

How it works

Elamipretide has a unique ability to concentrate in the inner mitochondrial membrane, where it binds to cardiolipin — a lipid essential for the electron transport chain's proper function. By stabilizing cardiolipin, it optimizes the electron transport chain, improves ATP (energy) production, and reduces the leakage of reactive oxygen species (ROS) that damage cells. This targeted mitochondrial support restores energy production at its source and protects cells from oxidative damage.

Frequently asked questions

FAQs

Improvements in physical stamina and "mental energy" are often gradual. While some patients report improved resilience within the first 14 days, the structural stabilization of the mitochondria is a cumulative process that typically shows significant results after 4–8 weeks of consistent use.

Elamipretide is generally well-tolerated. Potential effects may include: Temporary redness, stinging, or a small bump at the injection site (common). Mild dizziness or a brief "flushing" sensation shortly after injection. Rare: Headache.

Interested in Elamipretide (SS-31)?

Take a short assessment and a licensed provider will review if this treatment is right for you.

Check eligibility

Clinical Guidance Disclaimer

The information provided in this document is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. It should never replace sound clinical judgment or personalized advice of a qualified healthcare professional. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment protocol. Never disregard professional medical advice or delay in seeking it because of something you have read in these materials.

Liability & Indemnification

By utilizing this information, the user acknowledges and agrees that REBL and its affiliates, providers, and staff are not liable for any direct, indirect, or consequential damages resulting from the use or misuse of the information provided herein. Any reliance on the materials contained in this document is solely at the user's own risk.

Proprietary Rights & Use Restrictions

This document and its contents are the proprietary property of REBL. Unauthorized use, duplication, reproduction, or distribution of these materials—in whole or in part—without express written consent is strictly prohibited.